Sector: MedicalTARGACEPT INC. (NASDAQ: TRGT)
Headlines
- Semi-Annual Changes to the NASDAQ Biotechnology Index
Nov 13, 2009 08:02 PM | CSKI, HITK, NDAQ, PARD, SIGA, SPPI
- Targacept to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
Nov 11, 2009 08:55 AM | TRGT
- Targacept Reports Third Quarter 2009 Financial Results
Nov 05, 2009 04:05 PM | TRGT
- Depression Treatments Reviewed by NeuroInvestment
Nov 04, 2009 12:35 PM | COR, TRGT
- CED Sets Dates For Upcoming Conference Season
Nov 03, 2009 12:01 PM | GSK, TRGT, VRX
- Targacept to Report Third Quarter Financial Results on November 5, 2009
Oct 29, 2009 08:55 AM | TRGT
- Targacept Announces Participation in Upcoming Conferences
Oct 21, 2009 11:35 AM | TRGT
- Targacept Presents Data from Highly Successful Phase 2b Trial of TC-5214 as Augmentation Treatment for Major Depressive Disorder
Oct 15, 2009 06:35 PM | TRGT
- Best Performing Stocks - Third Quarter 2009
Oct 01, 2009 09:32 AM | AIG, AIXG, AM, ANN, ATPG, AWI
- Data to be Presented on Multiple Targacept NNR Therapeutics at Society for Neuroscience Satellite Symposium
Sep 10, 2009 08:55 AM | TRGT
- Targacept has profit in quarter: Large milestone payment by AstraZeneca credited for first profit in almost three years
Nov 06, 2009 07:51 AM | AZN, GSK, TC, TRGT
- Millions Raised in Fast Sale: Targacept CEO: People Excited About Our Future
Oct 09, 2009 05:53 AM | TRGT, TSCM
- Targacept Will Make Public Offering of Stock
Oct 08, 2009 05:52 PM | TRGT
- Targacept Reports $9.7 Million Loss in Second Quarter
Aug 06, 2009 05:54 AM | AZN, GSK, TC, TRGT
- Loss More Than in '08: Targacept Revenue Fell in 2nd Quarter
Aug 06, 2009 05:54 AM | AZN, GSK, TC, TRGT
- Targacept's CEO Got 10% Raise, Filing Shows: His Total Compensation for 2008 Dropped 15%
Apr 25, 2009 07:52 AM | AZN, GSK, RAI, TRGT
- Targacept CEO Got Pay Raise, but Earned Less Overall in 2008, Filing Shows
Apr 24, 2009 05:51 PM | AZN, GSK, RAI, TRGT
- Targacept Added to NASDAQ Biotechnology Index
Nov 16, 2009 11:11 AM | TRGT
- Mintz Levin Represents Targacept Inc. In Public Offering
Oct 21, 2009 05:51 PM | TRGT
- Targacept Announces Pricing of Common Stock Offering
Oct 08, 2009 10:53 AM | AZN, TRGT
- Targacept Announces Common Stock Offering
Oct 08, 2009 09:51 AM | AZN, TRGT
- Targacept Reports Second Quarter 2009 Financial Results
Aug 05, 2009 04:26 PM | TRGT
- Targacept to Report Second Quarter Financial Results on August 5, 2009
Jul 29, 2009 08:56 AM | TRGT
- Targacept Awarded Grant from Michael J. Fox Foundation to Conduct Research in the Treatment of Side Effects of Parkinson’s Disease Therapy
Jul 23, 2009 08:56 AM | TRGT
- Targacept’s TC-5214 Achieves All Primary and Secondary Outcome Measures in Phase 2b Trial as Augmentation Treatment for Major Depressive Disorder
Jul 15, 2009 07:12 AM | TRGT
- Targacept Announces Decision by AstraZeneca to Advance AZD3480 Program in ADHD
Jul 08, 2009 08:56 AM | TRGT
- Targacept Reports First Quarter 2009 Financial Results
May 11, 2009 07:56 AM | AZN, TRGT
- Form 4 TARGACEPT INC For: Oct 21 Filed by: Zorn Peter A (10K)
Oct 23, 2009 08:05 PM
- Form 4 TARGACEPT INC For: Oct 19 Filed by: Zorn Peter A (10K)
Oct 21, 2009 09:57 PM
- Form 4 TARGACEPT INC For: Oct 19 Filed by: Brennan Jeffrey P (10K)
Oct 21, 2009 09:42 PM
- Form 4 TARGACEPT INC For: Oct 16 Filed by: BVF INC/IL (10K)
Oct 20, 2009 06:59 PM
- Form 4 Dunbar Geoffrey C For: Sep 18 (10K)
Sep 18, 2009 10:52 PM
- Form 4 Dunbar Geoffrey C For: Sep 15 (10K)
Sep 17, 2009 01:33 PM
- Form 4 deBethizy J Donald For: Sep 04 (10K)
Sep 09, 2009 09:39 PM
- Form 4 Dunbar Geoffrey C For: Sep 04 (10K)
Sep 09, 2009 09:34 PM
- Form 4 Musso Alan A For: Sep 04 (10K)
Sep 09, 2009 09:29 PM
- Form 4 Caldwell William S For: Sep 04 (10K)
Sep 09, 2009 09:27 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
TRGT
|
Compare to S&P
|
| YTD |
526.40 %
|
418.43 %
|
| 4 Weeks |
7.47 %
|
6.31 %
|
| 12 Weeks |
54.54 %
|
45.70 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 112.82 %
|
|
EPS Growth in Last Year: 116.13 %
|
|
Sales Growth in Last Quarter: 347.46 %
|
|
Sales Growth in Last Quarter: 206.24 %
|
|
